Volker Wedershoven
Chief Executive Officer at ImevaX GmbH
Volker Wedershoven active positions
| Companies | Position | Start | End |
|---|---|---|---|
ImevaX GmbH
 ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Chief Executive Officer | - | - |
Career history of Volker Wedershoven
Former positions of Volker Wedershoven
| Companies | Position | Start | End |
|---|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Director/Board Member | - | 23/10/2022 |
Training of Volker Wedershoven
| Ludwig-Maximilians-Universität München | Masters Business Admin |
Statistics
International
| Germany | 3 |
| Norway | 2 |
Operational
| Chief Executive Officer | 1 |
| Masters Business Admin | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
| Private companies | 1 |
|---|---|
ImevaX GmbH
ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Health Technology |
- Stock Market
- Insiders
- Volker Wedershoven
- Experience
